In another study, a CAR19 T cell designed to constitutively secrete anti-PD-1 also showed enhanced anti-tumor activity in a CD19+ lung cancer xenograft model, with increased T cell proliferation and cytotoxicity, and prolonged survival (133). Here, PDCD1 is linked to neoplasm.